Clinical trial Recruiting at 1 site Interventional Ages 65 to 85

Effects of Nicotinamide Riboside on Cognition and Sleep in Older Adults

Official title: The Benefits of Nicotinamide Riboside Upon Cognition and Sleep in Older Veterans

Run by State University of New York at Buffalo · NCT05500170 · Data updated 2026-11-12

This study is testing if taking nicotinamide riboside can improve thinking skills and sleep quality in older adults who have trouble with both.

More Cognitive Impairment trials

Quick facts

Study typeInterventional
Ages65 Years to 85 Years
SexAll
Enrollment50 (estimated)
SponsorState University of New York at Buffalo
Academic / other
Locations3 sites (Buffalo, New York and 2 other locations)
StatusRecruiting
StartedApril 4, 2023
Main results expectedAugust 30, 2027
Study endsAugust 30, 2027
Registry record updatedSeptember 24, 2026
Trial IDNCT05500170 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are older adults aged 65 years and above who experience poor sleep quality as indicated by a Pittsburgh Sleep Quality Index score greater than 5.

Probably not a fit

Patients with dementia or significant cognitive impairment, as indicated by a VA-SLUMS score below 20, are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of nicotinamide riboside (NR) supplementation on cognitive function and sleep quality in older adults. It aims to determine whether increasing levels of nicotinamide adenine dinucleotide (NAD+) through NR can enhance brain-derived neurotrophic factor (BDNF) expression, which is crucial for cognitive health. Participants will be assessed using both subjective and objective measures of sleep and cognition, with a focus on those experiencing cognitive impairment and poor sleep quality. The study will also explore the relationship between NR supplementation and serum BDNF levels.

Why it matters

Potential benefit: If successful, this study could lead to new interventions that improve cognitive function and sleep quality in older adults, potentially delaying or preventing cognitive decline.

How similar studies have gone: While the specific approach of using nicotinamide riboside for cognitive and sleep improvement is novel, pre-clinical studies have shown promising results in enhancing cognition and sleep quality in animal models.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Sleep Quality. Pittsburgh Sleep Quality Index (PSQI) global score \>5

Exclusion Criteria:

* Dementia. Veteran Affairs - St. Louis University Mental Status questionnaire (VA-SLUMS) score \<20

Where it's running

  • Buffalo Veteran Affairs Medical Center
    Buffalo, New York, United States
    Recruiting
  • State University of New York at Buffalo
    Buffalo, New York, United States
    Not yet recruiting
  • University at Buffalo State University of New York
    Buffalo, New York, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.